Sarepta shares dive as gene therapy misses late-stage main goal
ReutersNov 3, 2025 9:38 PM
Shares in Sarepta Therapeutics SRPT.O slump nearly 21% to $5.1 in extended trading
A late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not meet main goal
Trial ran for nine years and was affected by the COVID-19 pandemic, which SRPT said impacted results
Up to last close, stock had fallen ~80% this year
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
U.S. October ADP Nonfarm: For U.S. Stocks, Employment Data Should Be Read in Reverse
In our view, the underlying softness in the U.S. labour market is unlikely to reverse soon, raising the odds of sustained Fed easing and leaving room for further equity upside.TradingKey
3 hours ago
Palantir Q3 Earnings Preview: Will Another 50% Growth Beat Continue Its Run of Defying Expectations?
TradingKey - Palantir (PLTR), the defense-focused AI software company, will report its Q3 2025 earnings after market close on November 3. Despite a 165% year-to-date surge in its stock price and persistent concerns over sky-high valuation, Wall Street expects Palantir to deliver another quarter ofTradingKey
19 hours ago
What Is Shiba Inu? Can Shiba Reach $1? SHIB Price Analysis and Forecast
Shiba Inu represents a novel asset class: born as a pure meme coin but evolving into an ecosystem with practical applications. SHIB’s future success depends on continued ecosystem development and effective deflationary mechanisms. Institutions generally see medium- to long-term growth potential, espTradingKey
Tue, Oct 28
Can Zcash (ZEC) Sustain Its Rally? What’s Next for Its Price Trajectory?
Launched in 2016, Zcash (ZEC) is a cryptocurrency focused on privacy protection. Its key innovation lies in selective privacy, allowing users to choose between transparent and shielded transactions.TradingKey
Sat, Oct 18
Understanding the Fed’s Overnight Reverse Repo(RRP), What Is the Relationship Between QT and Debt Ceiling
TradingKey - As the U.S. enters a new rate cycle, the quantitative tightening (QT)—initially launched to reduce the Federal Reserve’s bloated balance sheet following the COVID-19 pandemic—is also nearing its conclusion. A key metric in gauging when to end QT is the scale of the Fed’s ON RRP...TradingKey
Fri, Aug 15
